According to the new market research report “Bioinformatics Market – Advanced Technologies, Global Forecast and Winning Imperatives (2009-2014)”, published by MarketsandMarkets (www.marketsandmarkets.com), the global bioinformatics market is expected to reach a $8.3 billion by 2014 at a high CAGR of 24.8% from 2009-2014. While knowledge management formed the largest submarket is 2009 at $1.3 billion, the bioinformatics platforms market is expected to have greatest market share in 2014 at an estimated $3.9 billion due to rising demand from U.S. and Europe.Browse in-depth TOC on Bioinformatics Market.
Early buyers will receive 10% customization of reports
Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trials for drug discovery. Pharmaceutical companies have increased their focus on process improvement and quality in the current competitive scenario, as there is little scope for price escalation and product differentiation.SCOPE AND FORMAT
The report analyzes the global bioinformatics market into respective segments:* Bioinformatics platforms
* Content/knowledge management tools
* Bioinformatics services
* Bioinformatics applications
To register your participation, please click here
The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on Bioinformatics Market – Advanced Technologies, Global Forecast And Winning Imperatives (2009 – 2014) to be held on 5th Aug 2010.
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategic advisory reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.
M&M Banking and Financial Services practice recognizes the challenges that financial institutions face bringing the right products to market. Our reports and consulting practice provide a unique perspective allowing the financial institution to see and experience the best way to achieve their product goals. Through a mix of case studies, primary research, and business modeling we provide a 360° view to identify how you can create, capture, and keep the value of your product and out think the competition.
7557 Rambler Road,
Suite 727, Dallas, TX 75231